The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hello all,
Granted I have not been involved in this share for a while but part of me is waiting to see Avacta deliver on their timelines before getting involved.
They have missed the summer timeline of last year by a mile.
Alistair is always vague when it comes to timelines. They have not got a cat in hells chance of meeting the end of March timeline if we are to go by their track record. They have missed every timeline put out there so far.
The only thing this company seems efficient at is issuing employee share options. So let me get this right. They have missed their timelines given to the market yet seem happy to issue share options without one rapid test sold.
Can you imagine tell your boss you would get a task done by July or August and then him still waiting for the task to be done in March. You would be getting the P45 not share options!
So this company has big credibility issues which is why it fails to even pass the £3 barrier.
I am weary on Avacta although I made a profit overall on them as they are a frustrating company to be involved in.
If they get that test out in the next month or two then yes sit back and enjoy the ride.
But until they get their act together and meet a timeline then I am not convinced here.
Right now Avacta is worth a punt and nothing more. It's market cap is over valued based on what it has actually delivered. And before people talk about this deal or that deal. Or this takeover. That is all conjecture.
Show me the sales around this rapid test. What revenue have they made so far?
I would like Avacta to achieve more than many as I recommended it to others back in the day at around the £1 days. However buying in at these levels when they fail to deliver on the rapid test.
All that will happen here is you will get further delays, SP drifts until they deliver. Nothing happens quickly with Avacta so there will be more than enough time for people to top up on this share.
Gl all
Hello all,
I am glad to see Avacta is starting to come good.
They have delivered well behind the schedule that Alistair previously gave which was last Summer but the main thing is they are delivering.
I note in the recent RNS it said the CE approval would be end of the quarter....rather than end of this month. So are we actually talking more months for CE approval rather than weeks. And if so which quarter are we talking. I have always thought Avacta would be a strong company right from the 67p days but my gripe is that the information seems to be loose at times when it comes to timelines, some would say deliberately. I get that this company has still achieved things quicker than a good deal but it has been frustrating at times.
The other "elephant in the room" is Share placings and the price they would be done.
Shareholders already got sc*wed over once when this share was at £2.15 and the placing went at £1.20. That gives me some caution but overall better to be in than out.
Avacta raises £40M on the last placing - I think £10M was ear marked for the rapid test and £30M was for other areas or vice versa I cannot remember now.
My question is how much of that £40M got spent where. So did we end up having to spend more on the test which left less for the other areas etc. Also how much of the £40M is left?
Has anyone asked the board on future share placings versus having a working capital from revenue.
I wish the patient good luck in this one. I think it has a lot more legs from here but for me it has always been about when the company will actually deliver and not. The credibility of the company on timings has suffered as a result of previous missed timelines otherwise we would already be at nearer £5 than £3 by now.
I hope they do deliver and soon for the shareholders. I am most likely to join back again.
GL all
*sub 1p
Definitely looks like they are doing a few tricks at the moment re MMs.
The big background buyer that got in that others referred to, got in at these levels so at some point the price should move back up again. As it appears the SP only got pulled back in order for the MMs to fill a big buy order. The SP is now moving back up now.
This is a tricky one as part of me is looking at a nice profit, but my head tells me that taking any significant profit off these SP levels could in effect be giving my shares away if the SP is only at the start of its journey.
To get involved in a share at sub SP or a few pence (which is what this share is at even now) with so much interest in the company....see how much got traded yesterday (250 million shares got traded).....is really a buy and hold.
Gl all
Not because I did not buy any....but because I was going to average down and didn't
Bought in at the previous spike at 1.22 and then the price went to 0.6 which at such levels was always good to average down and get a big chunk in case it takes off. I didn't average down
Anyway checked the biggest movers last night and got a shock to see GST up there
The question is how high can this share go. My timing never works normally but forgetting about this for the last few weeks has worked nicely!
Gl all
Reposting of the post in the time of madness....thread below
Yesterday we all had the same information available to us (pretty much as PIs).
Some panicked and lost their heads. Some got stopped (stop losses) out of their investments.
The shrewd and the ones with the biggest b*lls made some good money from everyone's wobbles.
I had the same information as you and held. I actually topped up this morning based on news rather than based on no news.
Look around the board and see who posted what in the madness yesterday.
As it is how those who stay calm under pressure that you want around you when the ship wobbles
Gl all
Hello all,
I don't check the price every day but what I shock I got when checking the price 15 minutes ago as a holder of the share. I quickly checked for new of no sale but nope no news. So we are where we are.
It may well be the board have rejected all offers or it may well be the Sale price is not as favorable as people hoped. Or it may well be a leak. Who knows...
What we do know is that we are around the floor of this share so it does not make sense to bail on the share now till we at least get news behind the SP move, then you make your own decisions.
As for the smart alecs saying they would never touch the share and we were all greed chasers. Well no harm chasing a dream. And to be honest no one can cry over spilt milk as we had a good ride with this share so far.
This share was available after suspension at 14p a share. It shot up to 23p and took a slight breather. And even back then people were berating this board saying we shouldn't encourage people to enter the share at 20p. What happened next? The share stayed around 16p to 20p for a while. Many of us predicting 30p next stop and it went onto 42p even if it took a while. So that is 3x post suspension. It stayed mid 30s and above for a while. So if people wanted to take their profit they had plenty of chances. But a lot of us stayed in for the big pay day. Why?
Palladium prices
Board Strength
Board Investment in the company
Strong Resources
A board that kept delivering on its promises
Guess what? Until we get news to the contrary - none of the above has changed.
Even if there is no sale, this company still has strong prospects. But time will tell.
For me this is a hold until news and most likely a further hold at these prices as it makes no sense to sell at these levels.
The modest value for this company with resource updates is 60-70p range even without a sale.
Further upgrades and production progress will only increase that value.
Gl all
Hello Pedrol,
The way I worded it was not so clear. I invested at the 67p days. Sold out around the £1.50 to £1.90 ish but lost a good deal of the profit trying to trade the share. Rather than just buying and holding.
Gl all
Hello all,
Most stocks are down as people are unsure on the US election outcome and the impact on the global economy depending on who wins, as we all know.
However, right now for Avacta there is an elephant in the room and that is the rapid Antigen test delivery and / or timeline.
I am a previous investor in Avacta from the 67p days here. Potentially looking to get back into the stock. If we can get the rapid Antigen test delivered then I still believe this share would go North of £5. It has existing business aside from the rapid Antigen test with bigger potential in the long term. But many bought in for the medium term too.
My point that I made back in the summer was that timing of the rapid Antigen test was key, partly to get early mover advantage but also because the opportunity to monetise the rapid test solution and help fight Covid19 will only reduce as time goes by. As competitor products are hitting the market and the vaccine will hopefully be here soon. Even when the vaccine is here, there will still be a need for rapid testing for a period. My fear is whether Avacta will deliver the test now or how long it will take to deliver. As they have now missed the timelines given to the market which was summertime. I was hoping that would be during the summertime not at the end of it.
At the outset Alistair was particularly vague in his interviews to give timelines to deliver the test. I understand it was hard to predict. But others have by now so there seems to be issues around our test which hopefully will be sorted soon. He said sometime in the summer. Well summertime has now ended. Like it or not, Avacta has failed on that timeline and pretty miserably to be honest. I say that as I am frustrated that other companies seized the opportunity to get the product to market. The only updates we seem to get is employee share issues being handed out when the rapid test product has not even made it to market.
Aside from that negativity. At these levels of £160s...given you have the institutional backing at the £1.20s - this share still represents very good upside....if we can deliver the rapid Antigen test soon.
I am now at the conclusion that Avacta is definitely worth a punt but at investment levels where you can take a hit if they do not end up delivering the rapid Antigen test.
I hope the long-term holders get rewarded just like the NCYT holders were.
Gl all
I am happy it is moving nicely.
Hindsight is a great thing now. But that dip opportunity to 18p has rewarded the brave today.
Lets hope this time we can push on further. I can only think we will get a bid or resource update shortly.
RNS start of the week?
GL all
Medium term holder here
I decreased my holding by 60% a few weeks back thinking I could by in cheaper and now this!
What is behind the jump? Opening bid leak? Or a resource update imminent?
Given the flanks approval and the recent rise to 27p.
When are we due a resource update?
Hello all,
For the Abbot rapid test, are we saying it still needs clinical intervention ahead of getting the results back even though results take 15 mins?
If that is the case, then we are still in prime position with our Antigen test.
Thoughts? And what timelines from having the Avacta test to market?
*share price increase
Excellent post Alex,
Yes the significant resource update will hopefully be the trigger for the next share price update.
It also now paves the way for offers to come forward in the next 1-2 months. My forecast was a final offer by November.
I could not see an offer coming before the Monchetundra Flanks approval because that approval has such a huge impact on any offer price. A conditional offer before flanks approval was never likely for that reason.
I would agree that we are due a significant resource upgrade update 'shortly'. The most recent RNSs have been very matter of fact, which would indicate bigger news is on the way.
It be great if we get an offer before that. I expect the board only need communicate offers they are planning to recommend to the shareholders.
Gl all
25p*
of...25 finally came through today.
It might be a few months and 1 day later than I predicted lol but better late than never!
GL all
Well done all who kept the faith.
Avacta are finally starting to provide a constant stream of promising news which positions them in a good place to deliver on a huge scale re the rapid Antigen testing.
Not sure where the recent rises have come, maybe the sentiment is finally changing and the market are finally back on board that Avacta are looking like they will deliver what they promise.
Any strong news off this levels could finally bring a price inflection point.
Gl all
Hello Mike,
Well there are many options.
As well as selling the whole company if an offer at the right price comes in, they could just sell Monchetundra and issue a special dividend, and then mine WK themselves.
The placing is definitely a good sign. And puts the 'ball firmly back in their court (side)' in respect of the bidders